"10.1371_journal.pone.0047890","plos one","2012-11-15T00:00:00Z","Yaron D Barac; Orit Bar-Am; Esti Liani; Tamar Amit; Luba Frolov; Elena Ovcharenko; Itzchak Angel; Moussa B H Youdim; Ofer Binah","Department of Physiology and Biophysics, Faculty of Medicine, Technion, Haifa, Israel; Eve Topf and National Parkinson Foundation Center For Neurodegenerative Diseases Research and Department of Pharmacology, Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; A.P.C.T. Ltd., Ness-Ziona, Israel","Conceived and designed the experiments: YDB OBA EL TA MBHY OB. Performed the experiments: OBA EL LF EO. Analyzed the data: OBA EL TA IA. Wrote the paper: YDB OBA TA OB.","The authors have read the journal's policy and have the following conflicts: TVP1022 is in the development process of becoming a novel cardioprotective drug. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. IA is a one man consulting company A.P.C.T. Ltd, that was hired to help the authors conduct the TV0122 profiling.","2012","11","Yaron D Barac","YDB",9,TRUE,6,4,4,4,TRUE,FALSE,FALSE,0,NA,FALSE
